Literature DB >> 21533858

Implications of transcriptional factor, OCT-4, in human bladder malignancy and tumor recurrence.

Peng Huang1, Jie Chen, Lei Wang, Yanqun Na, Haruki Kaku, Hideo Ueki, Katsumi Sasaki, Ken Yamaguchi, Kai Zhang, Takashi Saika, Yasutomo Nasu, Masami Watanabe, Hiromi Kumon.   

Abstract

OCT-4, which is also known as POU5f1, is a key regulator of self-renewal in embryonic stem cells. The new cancer stem cell concept proposes that the expression of such genes is potentially correlated with tumorigenesis and can affect some aspects of the cancer behavior, such as recurrence or metastasis. This study investigated the association between OCT-4 expression in cancer tissues obtained by transurethral surgery and the clinical data to clarify the involvement of OCT-4 in human bladder malignancy. Immunohistochemical analysis demonstrated that a positive rate of OCT-4 expression was significantly associated with the higher-grade cancer (G2 and G3) in comparison with that of the lower grade (G1). In addition, positive OCT-4 expression was significantly associated with the intra-bladder tumor recurrence after the operation. The staining intensity of OCT-4 expression was also correlated with tumor recurrence. These data indicate that positive OCT-4 expression may be involved in the development of high-grade bladder cancer and with the bladder cancer recurrence. This is the first study showing a correlation between the expression of OCT-4 and bladder cancer recurrence. OCT-4 may be a valuable clinical marker for the progression of bladder cancer and may be an attractive therapeutic target for the development of new medicines for the treatment of malignancy.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21533858     DOI: 10.1007/s12032-011-9962-4

Source DB:  PubMed          Journal:  Med Oncol        ISSN: 1357-0560            Impact factor:   3.064


  17 in total

1.  Oct-3/4 is a dose-dependent oncogenic fate determinant.

Authors:  Sharon Gidekel; Galina Pizov; Yehudit Bergman; Eli Pikarsky
Journal:  Cancer Cell       Date:  2003-11       Impact factor: 31.743

Review 2.  OCT4: biological functions and clinical applications as a marker of germ cell neoplasia.

Authors:  L Cheng; M-T Sung; P Cossu-Rocca; T D Jones; G T MacLennan; J De Jong; A Lopez-Beltran; R Montironi; L H J Looijenga
Journal:  J Pathol       Date:  2007-01       Impact factor: 7.996

3.  Molecular clonal analysis of recurrent bladder cancer.

Authors:  Kerstin Junker; Michael Wolf; Jörg Schubert
Journal:  Oncol Rep       Date:  2005-08       Impact factor: 3.906

4.  Improved clonality analysis of multifocal bladder tumors by combination of histopathologic organ mapping, loss of heterozygosity, fluorescence in situ hybridization, and p53 analyses.

Authors:  Stefan Denzinger; Kristin Mohren; Ruth Knuechel; Peter J Wild; Maximilian Burger; Wolf F Wieland; Arndt Hartmann; Robert Stoehr
Journal:  Hum Pathol       Date:  2005-12-15       Impact factor: 3.466

5.  A human colon cancer cell capable of initiating tumour growth in immunodeficient mice.

Authors:  Catherine A O'Brien; Aaron Pollett; Steven Gallinger; John E Dick
Journal:  Nature       Date:  2006-11-19       Impact factor: 49.962

Review 6.  Signalling, cell cycle and pluripotency in embryonic stem cells.

Authors:  Tom Burdon; Austin Smith; Pierre Savatier
Journal:  Trends Cell Biol       Date:  2002-09       Impact factor: 20.808

7.  Immunological aspects of REIC/Dkk-3 in monocyte differentiation and tumor regression.

Authors:  Masami Watanabe; Yuji Kashiwakura; Peng Huang; Kazuhiko Ochiai; Junichiro Futami; Shun-Ai Li; Munenori Takaoka; Yasutomo Nasu; Masakiyo Sakaguchi; Nam-Ho Huh; Hiromi Kumon
Journal:  Int J Oncol       Date:  2009-03       Impact factor: 5.650

8.  Correlation between p53 mutations and HPV in bilharzial bladder cancer.

Authors:  Hussein M Khaled; Abeer A Bahnassi; Abdel-Rahman N Zekri; Hatem Aboul Kassem; Nadia Mokhtar
Journal:  Urol Oncol       Date:  2003 Sep-Oct       Impact factor: 3.498

9.  An embryonic stem cell-like gene expression signature in poorly differentiated aggressive human tumors.

Authors:  Ittai Ben-Porath; Matthew W Thomson; Vincent J Carey; Ruping Ge; George W Bell; Aviv Regev; Robert A Weinberg
Journal:  Nat Genet       Date:  2008-05       Impact factor: 38.330

10.  Clonal origin of bladder cancer.

Authors:  D Sidransky; P Frost; A Von Eschenbach; R Oyasu; A C Preisinger; B Vogelstein
Journal:  N Engl J Med       Date:  1992-03-12       Impact factor: 91.245

View more
  22 in total

1.  OCT4 controls mitotic stability and inactivates the RB tumor suppressor pathway to enhance ovarian cancer aggressiveness.

Authors:  E Comisso; M Scarola; M Rosso; S Piazza; S Marzinotto; Y Ciani; M Orsaria; L Mariuzzi; C Schneider; S Schoeftner; R Benetti
Journal:  Oncogene       Date:  2017-03-20       Impact factor: 9.867

2.  Increased expression of metastasis-associated in colon cancer-1 in renal cell carcinoma is associated with poor prognosis.

Authors:  Zhong Jin; Naijin Xu; Kai Guo; Peng Xu; Pengju Li; Yiming Zhang; Xiezhao Li; Shaobo Zheng; Chunxiao Liu; Abai Xu; Peng Huang
Journal:  Int J Clin Exp Pathol       Date:  2015-04-01

3.  Androgen receptor expands the population of cancer stem cells in upper urinary tract urothelial cell carcinoma cells.

Authors:  Chi-Cheng Chen; Teng-Fu Hsieh; Chi-Ping Huang; Ai-Lin Yu; Wen-Lin Chang; Chih-Rong Shyr
Journal:  Am J Cancer Res       Date:  2016-01-15       Impact factor: 6.166

4.  Predictive value of Sox2 expression in transurethral resection specimens in patients with T1 bladder cancer.

Authors:  Jun Ruan; Bingbing Wei; Zhuoqun Xu; Shudong Yang; You Zhou; Minhong Yu; Jiabei Liang; Ke Jin; Xing Huang; Peng Lu; Huan Cheng
Journal:  Med Oncol       Date:  2013-01-10       Impact factor: 3.064

5.  CpG oligodeoxyribonucleotide 7909 enhances radiosensitivity via downregulating Oct-4 expression in radioresistant lung cancer cells.

Authors:  Na Xing; Tiankui Qiao; Xibing Zhuang; Sujuan Yuan; Qi Zhang; Guoxiong Xu
Journal:  Onco Targets Ther       Date:  2015-06-12       Impact factor: 4.147

6.  Malignant mixed mullerian tumor: an immunohistochemical study.

Authors:  Zhanyong Bing; Theresa Pasha; Li-Ping Wang; Paul J Zhang
Journal:  Patholog Res Int       Date:  2012-07-10

7.  Attributes of Oct4 in stem cell biology: perspectives on cancer stem cells of the ovary.

Authors:  Chantel Samardzija; Michael Quinn; Jock K Findlay; Nuzhat Ahmed
Journal:  J Ovarian Res       Date:  2012-11-21       Impact factor: 4.234

8.  Clinical significance of CD24 as a predictor of bladder cancer recurrence.

Authors:  Chunxiao Liu; Shaobo Zheng; Haiyan Shen; Kai Xu; Jie Chen; Hulin Li; Yawen Xu; Abai Xu; Binshen Chen; Haruki Kaku; Yasutomo Nasu; Hiromi Kumon; Peng Huang; Masami Watanabe
Journal:  Oncol Lett       Date:  2013-05-21       Impact factor: 2.967

9.  Expression of OCT4A: the first step to the next stage of urothelial bladder cancer progression.

Authors:  Wojciech Jóźwicki; Anna A Brożyna; Jerzy Siekiera
Journal:  Int J Mol Sci       Date:  2014-09-11       Impact factor: 5.923

10.  Targeting of alpha-v integrins reduces malignancy of bladder carcinoma.

Authors:  Geertje van der Horst; Lieke Bos; Maaike van der Mark; Henry Cheung; Bertrand Heckmann; Philippe Clément-Lacroix; Giocondo Lorenzon; Rob C M Pelger; Rob F M Bevers; Gabri van der Pluijm
Journal:  PLoS One       Date:  2014-09-23       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.